Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcus Biosciences (RCUS) Depreciation & Amortization (CF): 2016-2024

Historic Depreciation & Amortization (CF) for Arcus Biosciences (RCUS) over the last 9 years, with Dec 2024 value amounting to $10.0 million.

  • Arcus Biosciences' Depreciation & Amortization (CF) changed negligibly% to $2.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.0 million, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of $10.0 million for FY2024, which is 25.00% up from last year.
  • Per Arcus Biosciences' latest filing, its Depreciation & Amortization (CF) stood at $10.0 million for FY2024, which was up 25.00% from $8.0 million recorded in FY2023.
  • In the past 5 years, Arcus Biosciences' Depreciation & Amortization (CF) ranged from a high of $10.0 million in FY2024 and a low of $3.0 million during FY2020.
  • In the last 3 years, Arcus Biosciences' Depreciation & Amortization (CF) had a median value of $8.0 million in 2023 and averaged $8.0 million.
  • In the last 5 years, Arcus Biosciences' Depreciation & Amortization (CF) declined by 16.15% in 2020 and then skyrocketed by 50.00% in 2022.
  • Yearly analysis of 5 years shows Arcus Biosciences' Depreciation & Amortization (CF) stood at $3.0 million in 2020, then surged by 33.33% to $4.0 million in 2021, then surged by 50.00% to $6.0 million in 2022, then soared by 33.33% to $8.0 million in 2023, then grew by 25.00% to $10.0 million in 2024.